Daniel Moreira-Gonçalves Selected Research

Daniel Moreira-Gonçalves Research Topics

Disease

8	Neoplasms (Cancer) 08/2022 - 06/2014
8	Fibrosis (Cirrhosis) 09/2020 - 06/2009
5	Cachexia 08/2022 - 02/2015
4	Pulmonary Hypertension 09/2020 - 03/2008
3	Carcinoma (Carcinomatosis) 12/2018 - 07/2013
3	Hypertrophy 10/2018 - 06/2009
2	Inflammation (Inflammations) 08/2022 - 07/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2019
2	Atrophy 09/2020 - 01/2018
2	Heart Failure 02/2015 - 03/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2014 - 07/2013
2	Body Weight (Weight, Body) 07/2013 - 09/2011
1	Heart Diseases (Heart Disease) 08/2022
1	Chronic Disease (Chronic Diseases) 08/2022
1	Pain (Aches) 08/2021
1	Wounds and Injuries (Trauma) 08/2021
1	COVID-19 01/2021
1	Left Ventricular Dysfunction 09/2020
1	Pulmonary Arterial Hypertension 03/2019
1	Hyperplasia 10/2018
1	Necrosis 07/2017
1	Frailty 07/2017
1	Carcinogenesis 02/2015
1	Obesity 01/2015
1	Myocardial Infarction 01/2015
1	Muscular Atrophy (Muscle Atrophy) 06/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2013
1	Hyperglycemia 02/2013
1	Right Ventricular Hypertrophy 03/2008

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 07/2017 - 02/2013
3	MonocrotalineIBA 09/2020 - 03/2008
3	Adenosine Triphosphate (ATP)IBA 12/2018 - 06/2014
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2022 - 11/2015
2	C-Reactive ProteinIBA 08/2022 - 07/2013
2	Messenger RNA (mRNA)IBA 09/2020 - 11/2015
2	Therapeutic UsesIBA 12/2018 - 01/2018
2	ProteomeIBA 12/2018 - 02/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 03/2008
2	MyostatinIBA 02/2015 - 07/2013
2	Matrix Metalloproteinases (MMPs)IBA 07/2013 - 09/2011
2	salicylhydroxamic acid (SHAM)IBA 09/2011 - 06/2009
1	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2022
1	ReninIBA 08/2022
1	Vascular Endothelial Growth Factor CIBA 08/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2022
1	Interleukin-6 (Interleukin 6)IBA 08/2022
1	GhrelinIBA 08/2022
1	Biomarkers (Surrogate Marker)IBA 08/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	ChromatinIBA 01/2022
1	EnzymesIBA 01/2022
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2022
1	mesoglycanIBA 08/2021
1	Endothelin-1 (Endothelin 1)IBA 09/2020
1	PolyphenolsIBA 03/2019
1	xanthohumolIBA 03/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2018
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2018
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 01/2018
1	terameprocolIBA 11/2017
1	HMGB1 Protein (HMG1)IBA 11/2017
1	Tumor Biomarkers (Tumor Markers)IBA 07/2017
1	Biological ProductsIBA 07/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2017
1	Interleukin-1 (Interleukin 1)IBA 07/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 11/2015
1	Ventricular MyosinsIBA 11/2015
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 09/2015
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 02/2015
1	CytokinesIBA 02/2015
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 02/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 06/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2013
1	Peptide Hydrolases (Proteases)FDA Link 07/2013
1	Streptozocin (Streptozotocin)FDA Link 02/2013
1	Advanced Glycation End ProductsIBA 09/2011
1	1- (1,3- benzodioxol- 5- ylcarbonyl)piperidineIBA 09/2011
1	progelatinaseIBA 09/2011
1	ApelinIBA 06/2009
1	Monoclonal AntibodiesIBA 03/2008
1	Etanercept (Enbrel)FDA Link 03/2008

Therapy/Procedure

5	Therapeutics 08/2022 - 02/2015
1	Length of Stay 07/2017
1	Endurance Training 02/2015